Droms Strauss Advisors’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.67M Buy
233,904
+13,645
+6% +$330K 1.29% 19
2026
Q1
$5.34M Sell
220,259
-1,012
-0.5% -$24.6K 1.4% 18
2025
Q4
$5.37M Buy
221,271
+10,110
+5% +$246K 1.41% 18
2025
Q3
$5.14M Buy
211,161
+20,260
+11% +$491K 1.49% 15
2025
Q2
$4.63M Buy
190,901
+753
+0.4% +$18.2K 1.42% 15
2025
Q1
$4.6M Buy
190,148
+12,992
+7% +$312K 1.58% 11
2024
Q4
$4.24M Buy
177,156
+8,365
+5% +$201K 1.39% 17
2024
Q3
$4.11M Buy
168,791
+5,277
+3% +$127K 1.46% 14
2024
Q2
$3.88M Buy
163,514
+5,912
+4% +$140K 1.4% 16
2024
Q1
$3.75M Buy
157,602
+54,740
+53% +$1.3M 1.37% 14
2023
Q4
$2.46M Buy
102,862
+2,273
+2% +$53K 0.96% 19
2023
Q3
$2.33M Buy
100,589
+3,472
+4% +$81K 1% 19
2023
Q2
$2.27M Buy
+97,117
New +$2.3M 0.95% 19

Other funds holding IBDS

Droms Strauss Advisors's IBDS Position: Q2 2026 in Review

Droms Strauss Advisors increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 6.2% in Q2 2026, buying an estimated $330K and bringing the position to 233,904 shares worth $5.67M. The position accounts for 1.29% of the portfolio, ranked #19.

Droms Strauss Advisors first reported a position in IBDS in Q2 2023 and has held it in 13 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Droms Strauss Advisors held 233,904 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $5.67M as of Q2 2026.
  • Droms Strauss Advisors bought 13,645 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $330K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 1.29% of Droms Strauss Advisors's portfolio in Q2 2026, its #19 holding.
  • Droms Strauss Advisors first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2023 and has held it in 13 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Droms Strauss Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.